Cargando…
Respiratory rate index utility in high-flow nasal cannula oxygen therapy in COVID-19 pneumonia; what are the perfect boundaries?
Autores principales: | Mazza, Mariano, Di Costanzo, Domenica, Esquinas, Antonio M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960153/ https://www.ncbi.nlm.nih.gov/pubmed/35396194 http://dx.doi.org/10.1016/j.resinv.2022.02.008 |
Ejemplares similares
-
High-flow nasal oxygen decrease mortality in patients with severe SARS-CoV-2 pneumonia? Issues and controversies
por: Di Costanzo, Domenica, et al.
Publicado: (2022) -
High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab
por: Mandal, M., et al.
Publicado: (2022) -
High-flow nasal cannula oxygenation for awake craniotomy in patients with obesity: looking beyond oxygenation
por: Karim, Habib Md Reazaul, et al.
Publicado: (2022) -
Escalation to high‐flow nasal cannula oxygen in hematological malignancy: the right choice at the right moment?
por: Buonanno, Pasquale, et al.
Publicado: (2022) -
Methodological Insight to the High-Flow Nasal Cannula Oxygenation in Elderly Undergoing Endoscopic Retrograde Cholangiopancreatography
por: Notaro, Salvatore, et al.
Publicado: (2022)